NZ 612095 Disclosed is a use of an infant formula for the manufacture of a medicament for treatment of infant formula intolerance and for the treatment of gastroesophageal reflux, wherein the medicament is suitable for administration to an infant and has an energy content of 200 to less than 600 kilocalories per litre of formula, and wherein the medicament improves infant formula tolerance in an infant.